Global Bio-Implants Market By Types (Cardiovascular implants (Stents, Pacing Devices, Grafts, Structural Cardiac Implants (Heart Valves, Tissue Heart Valves, Implantable Heart Monitors, Insertable Loop Recorders, Others) Orthopedic Implants and Trauma, Knee Replacement Implants, Hip Replacement Implants, Ankle Replacement Implants, Shoulder Replacement Implants, Others), Dental Implants (Endosteal implants, Subperiosteal implants) Ophthalmic Implants (Intraocular lens, Glaucoma and Other Lenses), Spinal Implants (Cervical Implants, Thoracolumbar Implants, Motion Preservation Implants, Others)Others) By Materials (Bioceramics, Polymers, Natural Polymers, Metals and Alloys, Others) By Origin (Allograft, Synthetic, Xenograft) By End Users (Hospitals and Clinics, Specialty Clinics, Ambulatory Centers, Dental Clinics, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Bio-implants are bioengineered goods made of biosynthetic materials like collagen, as well as tissue-engineered products like artificial skin and tissue substitutes. Bio-implants are used in organ transplantation as well as tissue regeneration. Bio-implants are used in a range of medical sectors, including cardiovascular, orthopaedic, neurological, and dental implants. Bioengineered devices composed of biomaterials such as collagen and other tissue-engineered products are known as transplantable bio-implants. Due to rising ageing population and the accompanying difficulties of osteoporosis and osteoarthritis, bioimplants are becoming increasingly significant in modern culture. To manufacture biocompatible products with acceptable lifespans, the manufacturing of bioimplants necessitates an understanding of both mechanical engineering and biomedical science. A good material selection is required for bioimplants to provide long-term and reliable service, which is heavily reliant on a thorough understanding of the material properties. Furthermore, greater consumer awareness of aesthetic implants, technological improvements in implants, and rising demand for non-surgical bio-implants are all expected to contribute considerably to bio-implants market growth. A growing number of mergers and acquisitions, new product debuts, an increasing number of partnerships and collaborations, and increased R&D efforts are just a few of the drivers driving market expansion.
In terms of revenue, global bio-implants market was valued at US$ 117 Bn in 2021 growing at a CAGR of 10% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Bio-Implants Market Revenue & Forecast, (US$ Million), 2015 – 2030
Type Outlook
Based on the type outlook, the global bio-implants market is segmented into cardiovascular implants, orthopaedic implants and trauma, dental implants, ophthalmic implants, spinal implants and others. Dental implants are estimated to be the fastest growing segment in the global bio-implants market in the upcoming years. The introduction of dental implant, an artificial device used to replace missing teeth, was a significant achievement in dentistry. Dental implant technology advancements have led in increased patient comfort and appearance. Dentists also prefer dental implants over traditional methods of rehabilitation due to their higher success rates. Adults aged between 20 to 64 have an average of 25 of their 32 natural teeth remaining, according to the National Institute of Dental and Craniofacial Research. Dental implants are proving to be an effective management method for many of these adults with missing teeth. Dental implants provide for greater restoration of normal mouth function while eliminating the frequent drawbacks of other types of repairs. Dental implants have progressed dramatically throughout history, particularly in the modern period. Recent technical advancements have broadened the types of implants accessible, as well as the procedures for inserting them. These advancements assist both patients and clinicians by allowing them to choose and implement a configuration that is specific to their needs.
Material Outlook
Surface modification of biomaterials is critical in determining the result of the interaction between human biology and materials. Significant advancements in biomaterials research have expanded the field of usage for a wide range of orthopaedic and dental implants such as total bone replacement, fracture fixation, dental screws, joint arthrodesis, and so on. The effectiveness of bioimplants is essentially determined not just by their bulk qualities, but also by the properties of their surfaces, which interact with human body tissues. As a result, the progress of global bio-implants market has reached a point of material selection based on unique qualities of selected specific materials.
Region Outlook
Based on region, North America had the highest share in the bio-implants market in the year 2021. Due to the rise in cardiovascular disorders there has been a rise in demand for bio-implants such as stents, pacemakers across United States and Canada. Moreover, there has been rising awareness about the effectiveness of cosmetic implants and technological advancements. Over the years, North America has developed a strong healthcare infrastructure which has supported the advancements of various bio-implants leading to the growth of the overall market.
Competitive Landscape
The report provides both, qualitative and quantitative research of global bio-implants market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global bio-implants market are:
- Alpha-Bio Tec Ltd.
- Arthrex, Inc.
- Auxein Medical
- BioHorizons
- BioImplant Ceramic
- Biorad Medisys Pvt Ltd.
- Biotec
- Exactech, Inc.
- Medical Devices Business Services, Inc.
- Medtronic
- Redline Surgical
- Straumann USA, LLC
- Stryker
- UX Themes
- Zimmer Biomet
- Other Industry Participants
Global Bio-implants Market:
By Types
- Cardiovascular implants
- Stents
- Pacing devices
- Grafts
- Structural Cardiac Implants
- Heart Valves
- Tissue Heart Valves
- Implantable Heart Monitors
- Insertable Loop Recorders
- Others
- Orthopedic Implants and trauma
- Knee replacement implants
- Hip replacement implants
- Ankle replacement implants
- Shoulder replacement implants
- Others
- Dental Implants
- Endosteal implants
- Subperiosteal implants
- Ophthalmic implants
- Intraocular lens
- Glaucoma and other Lenses
- Spinal Implants
- Cervical implants
- Thoracolumbar implants
- Motion preservation implants
- Others
- Others
By Materials
- Bioceramics
- Polymers
- Natural polymers
- Metals and alloys
- Others
By Origin
- Allograft
- Synthetic
- Xenograft
By End Users
- Hospitals and clinics
- Specialty clinics
- Ambulatory Centers
- Dental clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Bio-Implants Market
6.
Market
Synopsis: Bio-Implants Market
7.
Bio-Implants
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Bio-Implants Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Bio-Implants Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid-19 on Bio-Implants Market
8.
Global Bio-Implants
Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global Bio-Implants Market Revenue (US$ Mn)
8.2. Global Bio-Implants Market Revenue (US$ Mn)
and Forecasts, By Types
8.2.1. Cardiovascular implants (Definition, Market Estimation and
Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022
– 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Stents , Pacing devices , Grafts , Structural Cardiac Implants )
8.2.1.1.
Stents
8.2.1.2.
Pacing
devices
8.2.1.3.
Grafts
8.2.1.4.
Structural
Cardiac Implants
8.2.1.4.1.
Heart
Valves
8.2.1.4.2.
Tissue
Heart Valves
8.2.1.4.3.
Implantable
Heart Monitors
8.2.1.4.4.
Insertable
Loop Recorders
8.2.1.4.5.
Others
8.2.2. Orthopedic Implants and trauma (Definition,
Market Estimation and Penetration, 2015 - 2021, Market Estimation (2015 - 2021),
Market Forecast (2022 – 2030), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Knee replacement implants , Hip replacement
implants, Ankle replacement implants, Shoulder replacement implants, Others)
8.2.2.1.
Knee
replacement implants
8.2.2.2.
Hip
replacement implants
8.2.2.3.
Ankle
replacement implants
8.2.2.4.
Shoulder
replacement implants
8.2.2.5.
Others
8.2.3. Dental Implants (Definition, Market Estimation and
Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022
– 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Endosteal implants , Subperiosteal implants)
8.2.3.1.
Endosteal
implants
8.2.3.2.
Subperiosteal
implants
8.2.4. Ophthalmic implants (Definition, Market Estimation and
Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022
– 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Intraocular lens, Glaucoma and other Lenses )
8.2.4.1.
Intraocular
lens
8.2.4.2.
Glaucoma
and other Lenses
8.2.5. Spinal Implants (Definition, Market Estimation and
Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022
– 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America,
Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on
Cervical implants , Thoracolumbar implants , Motion preservation implants ,
Others )
8.2.5.1.
Cervical
implants
8.2.5.2.
Thoracolumbar
implants
8.2.5.3.
Motion
preservation implants
8.2.5.4.
Others
8.2.6. Others
8.2.6.1.
Definition
8.2.6.2.
Market
Estimation and Penetration, 2015 - 2021
8.2.6.3.
Market
Forecast, 2022 – 2030
8.2.6.4.
Compound
Annual Growth Rate (CAGR)
8.2.6.5.
Regional
Bifurcation
8.2.6.5.1.
North
America
8.2.6.5.1.1. Market Estimation, 2015 - 2021
8.2.6.5.1.2. Market Forecast, 2022 – 2030
8.2.6.5.2.
Europe
8.2.6.5.2.1. Market Estimation, 2015 - 2021
8.2.6.5.2.2. Market Forecast, 2022 – 2030
8.2.6.5.3.
Asia
Pacific
8.2.6.5.3.1. Market Estimation, 2015 - 2021
8.2.6.5.3.2. Market Forecast, 2022 – 2030
8.2.6.5.4.
Middle
East and Africa
8.2.6.5.4.1. Market Estimation, 2015 - 2021
8.2.6.5.4.2. Market Forecast, 2022 – 2030
8.2.6.5.5.
Latin
America
8.2.6.5.5.1. Market Estimation, 2015 - 2021
8.2.6.5.5.2. Market Forecast, 2022 – 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Types
9.
Global Bio-Implants
Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global Bio-Implants Market Revenue (US$ Mn)
and Forecasts, By Materials
9.2.1. Bioceramics
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.1.3.
Market
Forecast, 2022 – 2030
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2021
9.2.1.5.1.2. Market Forecast, 2022 – 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2021
9.2.1.5.2.2. Market Forecast, 2022 – 2030
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2021
9.2.1.5.3.2. Market Forecast, 2022 – 2030
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2021
9.2.1.5.4.2. Market Forecast, 2022 – 2030
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2021
9.2.1.5.5.2. Market Forecast, 2022 – 2030
9.2.2. Polymers
9.2.2.1.
Definition
9.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market
Forecast, 2022 – 2030
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2021
9.2.2.5.1.2. Market Forecast, 2022 – 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2021
9.2.2.5.2.2. Market Forecast, 2022 – 2030
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2021
9.2.2.5.3.2. Market Forecast, 2022 – 2030
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2021
9.2.2.5.4.2. Market Forecast, 2022 – 2030
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2021
9.2.2.5.5.2. Market Forecast, 2022 – 2030
9.2.3. Natural polymers
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market
Forecast, 2022 – 2030
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2021
9.2.3.5.1.2. Market Forecast, 2022 – 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2021
9.2.3.5.2.2. Market Forecast, 2022 – 2030
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2021
9.2.3.5.3.2. Market Forecast, 2022 – 2030
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2021
9.2.3.5.4.2. Market Forecast, 2022 – 2030
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2021
9.2.3.5.5.2. Market Forecast, 2022 – 2030
9.2.4. Metals and alloys
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.4.3.
Market
Forecast, 2022 – 2030
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2021
9.2.4.5.1.2. Market Forecast, 2022 – 2030
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2021
9.2.4.5.2.2. Market Forecast, 2022 – 2030
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2021
9.2.4.5.3.2. Market Forecast, 2022 – 2030
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2021
9.2.4.5.4.2. Market Forecast, 2022 – 2030
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2021
9.2.4.5.5.2. Market Forecast, 2022 – 2030
9.2.5. Others
9.2.5.1.
Definition
9.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
9.2.5.3.
Market
Forecast, 2022 – 2030
9.2.5.4.
Compound
Annual Growth Rate (CAGR)
9.2.5.5.
Regional
Bifurcation
9.2.5.5.1.
North
America
9.2.5.5.1.1. Market Estimation, 2015 - 2021
9.2.5.5.1.2. Market Forecast, 2022 – 2030
9.2.5.5.2.
Europe
9.2.5.5.2.1. Market Estimation, 2015 - 2021
9.2.5.5.2.2. Market Forecast, 2022 – 2030
9.2.5.5.3.
Asia
Pacific
9.2.5.5.3.1. Market Estimation, 2015 - 2021
9.2.5.5.3.2. Market Forecast, 2022 – 2030
9.2.5.5.4.
Middle
East and Africa
9.2.5.5.4.1. Market Estimation, 2015 - 2021
9.2.5.5.4.2. Market Forecast, 2022 – 2030
9.2.5.5.5.
Latin
America
9.2.5.5.5.1. Market Estimation, 2015 - 2021
9.2.5.5.5.2. Market Forecast, 2022 – 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Materials
10. Global Bio-Implants Market Analysis and
Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Bio-Implants Market Revenue (US$ Mn)
and Forecasts, By Origin
10.2.1. Allograft
10.2.1.1.
Definition
10.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market
Forecast, 2022 – 2030
10.2.1.4.
Compound
Annual Growth Rate (CAGR)
10.2.1.5.
Regional
Bifurcation
10.2.1.5.1.
North
America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast, 2022 – 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 – 2030
10.2.1.5.3.
Asia
Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market Forecast, 2022 – 2030
10.2.1.5.4.
Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast, 2022 – 2030
10.2.1.5.5.
Latin
America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast, 2022 – 2030
10.2.2. Synthetic
10.2.2.1.
Definition
10.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market
Forecast, 2022 – 2030
10.2.2.4.
Compound
Annual Growth Rate (CAGR)
10.2.2.5.
Regional
Bifurcation
10.2.2.5.1.
North
America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast, 2022 – 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 – 2030
10.2.2.5.3.
Asia
Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market Forecast, 2022 – 2030
10.2.2.5.4.
Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast, 2022 – 2030
10.2.2.5.5.
Latin
America
10.2.2.5.5.1. Market Estimation, 2015 - 2021
10.2.2.5.5.2. Market Forecast, 2022 – 2030
10.2.3. Xenograft
10.2.3.1.
Definition
10.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market
Forecast, 2022 – 2030
10.2.3.4.
Compound
Annual Growth Rate (CAGR)
10.2.3.5.
Regional
Bifurcation
10.2.3.5.1.
North
America
10.2.3.5.1.1. Market Estimation, 2015 - 2021
10.2.3.5.1.2. Market Forecast, 2022 – 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2021
10.2.3.5.2.2. Market Forecast, 2022 – 2030
10.2.3.5.3.
Asia
Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2021
10.2.3.5.3.2. Market Forecast, 2022 – 2030
10.2.3.5.4.
Middle
East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2021
10.2.3.5.4.2. Market Forecast, 2022 – 2030
10.2.3.5.5.
Latin
America
10.2.3.5.5.1. Market Estimation, 2015 - 2021
10.2.3.5.5.2. Market Forecast, 2022 – 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Origin
11. Global Bio-Implants Market Analysis and
Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Bio-Implants Market Revenue (US$ Mn)
and Forecasts, By End users
11.2.1. Hospitals and clinics
11.2.1.1.
Definition
11.2.1.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.1.3.
Market
Forecast, 2022 – 2030
11.2.1.4.
Compound
Annual Growth Rate (CAGR)
11.2.1.5.
Regional
Bifurcation
11.2.1.5.1.
North America
11.2.1.5.1.1. Market Estimation, 2015 - 2021
11.2.1.5.1.2. Market Forecast, 2022 – 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1. Market Estimation, 2015 - 2021
11.2.1.5.2.2. Market Forecast, 2022 – 2030
11.2.1.5.3.
Asia
Pacific
11.2.1.5.3.1. Market Estimation, 2015 - 2021
11.2.1.5.3.2. Market Forecast, 2022 – 2030
11.2.1.5.4.
Middle
East and Africa
11.2.1.5.4.1. Market Estimation, 2015 - 2021
11.2.1.5.4.2. Market Forecast, 2022 – 2030
11.2.1.5.5.
Latin
America
11.2.1.5.5.1. Market Estimation, 2015 - 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2. Specialty clinics
11.2.2.1.
Definition
11.2.2.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.2.3.
Market
Forecast, 2022 – 2030
11.2.2.4.
Compound
Annual Growth Rate (CAGR)
11.2.2.5.
Regional
Bifurcation
11.2.2.5.1.
North
America
11.2.2.5.1.1. Market Estimation, 2015 - 2021
11.2.2.5.1.2. Market Forecast, 2022 – 2030
11.2.2.5.2.
Europe
11.2.2.5.2.1. Market Estimation, 2015 - 2021
11.2.2.5.2.2. Market Forecast, 2022 – 2030
11.2.2.5.3.
Asia
Pacific
11.2.2.5.3.1. Market Estimation, 2015 - 2021
11.2.2.5.3.2. Market Forecast, 2022 – 2030
11.2.2.5.4.
Middle East
and Africa
11.2.2.5.4.1. Market Estimation, 2015 - 2021
11.2.2.5.4.2. Market Forecast, 2022 – 2030
11.2.2.5.5.
Latin
America
11.2.2.5.5.1. Market Estimation, 2015 - 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.2.3. Ambulatory Centers
11.2.3.1.
Definition
11.2.3.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.3.3.
Market
Forecast, 2022 – 2030
11.2.3.4.
Compound
Annual Growth Rate (CAGR)
11.2.3.5.
Regional
Bifurcation
11.2.3.5.1.
North
America
11.2.3.5.1.1. Market Estimation, 2015 - 2021
11.2.3.5.1.2. Market Forecast, 2022 – 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1. Market Estimation, 2015 - 2021
11.2.3.5.2.2. Market Forecast, 2022 – 2030
11.2.3.5.3.
Asia
Pacific
11.2.3.5.3.1. Market Estimation, 2015 - 2021
11.2.3.5.3.2. Market Forecast, 2022 – 2030
11.2.3.5.4.
Middle
East and Africa
11.2.3.5.4.1. Market Estimation, 2015 - 2021
11.2.3.5.4.2. Market Forecast, 2022 – 2030
11.2.3.5.5.
Latin
America
11.2.3.5.5.1. Market Estimation, 2015 - 2021
11.2.3.5.5.2. Market Forecast, 2022 – 2030
11.2.4. Dental clinics
11.2.4.1.
Definition
11.2.4.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.4.3.
Market
Forecast, 2022 – 2030
11.2.4.4.
Compound
Annual Growth Rate (CAGR)
11.2.4.5.
Regional
Bifurcation
11.2.4.5.1.
North
America
11.2.4.5.1.1. Market Estimation, 2015 - 2021
11.2.4.5.1.2. Market Forecast, 2022 – 2030
11.2.4.5.2.
Europe
11.2.4.5.2.1. Market Estimation, 2015 - 2021
11.2.4.5.2.2. Market Forecast, 2022 – 2030
11.2.4.5.3.
Asia
Pacific
11.2.4.5.3.1. Market Estimation, 2015 - 2021
11.2.4.5.3.2. Market Forecast, 2022 – 2030
11.2.4.5.4.
Middle
East and Africa
11.2.4.5.4.1. Market Estimation, 2015 - 2021
11.2.4.5.4.2. Market Forecast, 2022 – 2030
11.2.4.5.5.
Latin
America
11.2.4.5.5.1. Market Estimation, 2015 - 2021
11.2.4.5.5.2. Market Forecast, 2022 – 2030
11.2.5. Others
11.2.5.1.
Definition
11.2.5.2.
Market
Estimation and Penetration, 2015 - 2021
11.2.5.3.
Market
Forecast, 2022 – 2030
11.2.5.4.
Compound
Annual Growth Rate (CAGR)
11.2.5.5.
Regional
Bifurcation
11.2.5.5.1.
North
America
11.2.5.5.1.1. Market Estimation, 2015 - 2021
11.2.5.5.1.2. Market Forecast, 2022 – 2030
11.2.5.5.2.
Europe
11.2.5.5.2.1. Market Estimation, 2015 - 2021
11.2.5.5.2.2. Market Forecast, 2022 – 2030
11.2.5.5.3.
Asia
Pacific
11.2.5.5.3.1. Market Estimation, 2015 - 2021
11.2.5.5.3.2. Market Forecast, 2022 – 2030
11.2.5.5.4.
Middle
East and Africa
11.2.5.5.4.1. Market Estimation, 2015 - 2021
11.2.5.5.4.2. Market Forecast, 2022 – 2030
11.2.5.5.5.
Latin
America
11.2.5.5.5.1. Market Estimation, 2015 - 2021
11.2.5.5.5.2. Market Forecast, 2022 – 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End users
12. North America Bio-Implants Market Analysis
and Forecasts, 2022 – 2030
12.1. Overview
12.1.1. North America Bio-Implants Market Revenue
(US$ Mn)
12.2. North America Bio-Implants Market Revenue
(US$ Mn) and Forecasts, By Types
12.2.1. Cardiovascular implants
12.2.1.1.
Stents
12.2.1.2.
Pacing
devices
12.2.1.3.
Grafts
12.2.1.4.
Structural
Cardiac Implants
12.2.1.4.1.
Heart
Valves
12.2.1.4.2.
Tissue
Heart Valves
12.2.1.4.3.
Implantable
Heart Monitors
12.2.1.4.4.
Insertable
Loop Recorders
12.2.1.4.5.
Others
12.2.2. Orthopedic Implants and trauma
12.2.2.1.
Knee
replacement implants
12.2.2.2.
Hip
replacement implants
12.2.2.3.
Ankle
replacement implants
12.2.2.4.
Shoulder
replacement implants
12.2.2.5.
Others
12.2.3. Dental Implants
12.2.3.1.
Endosteal
implants
12.2.3.2.
Subperiosteal
implants
12.2.4. Ophthalmic implants
12.2.4.1.
Intraocular
lens
12.2.4.2.
Glaucoma
and other Lenses
12.2.5. Spinal Implants
12.2.5.1.
Cervical
implants
12.2.5.2.
Thoracolumbar
implants
12.2.5.3.
Motion
preservation implants
12.2.5.4.
Others
12.2.6. Others
12.3. North America Bio-Implants Market Revenue
(US$ Mn) and Forecasts, By Materials
12.3.1. Bioceramics
12.3.2. Polymers
12.3.3. Natural polymers
12.3.4. Metals and alloys
12.3.5. Others
12.4. North America Bio-Implants Market Revenue
(US$ Mn) and Forecasts, By Origin
12.4.1. Allograft
12.4.2. Synthetic
12.4.3. Xenograft
12.5. North America Bio-Implants Market Revenue
(US$ Mn) and Forecasts, By End users
12.5.1. Hospitals and clinics
12.5.2. Specialty clinics
12.5.3. Ambulatory Centers
12.5.4. Dental clinics
12.5.5. Others
12.6. North America Bio-Implants Market Revenue
(US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1.
U.S Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
12.6.1.1.1.
Cardiovascular
implants
12.6.1.1.1.1. Stents
12.6.1.1.1.2. Pacing devices
12.6.1.1.1.3. Grafts
12.6.1.1.1.4. Structural Cardiac Implants
12.6.1.1.1.4.1. Heart Valves
12.6.1.1.1.4.2. Tissue Heart Valves
12.6.1.1.1.4.3. Implantable Heart Monitors
12.6.1.1.1.4.4. Insertable Loop Recorders
12.6.1.1.1.4.5. Others
12.6.1.1.2.
Orthopedic
Implants and trauma
12.6.1.1.2.1. Knee replacement implants
12.6.1.1.2.2. Hip replacement implants
12.6.1.1.2.3. Ankle replacement implants
12.6.1.1.2.4. Shoulder replacement implants
12.6.1.1.2.5. Others
12.6.1.1.3.
Dental
Implants
12.6.1.1.3.1. Endosteal implants
12.6.1.1.3.2. Subperiosteal implants
12.6.1.1.4.
Ophthalmic
implants
12.6.1.1.4.1. Intraocular lens
12.6.1.1.4.2. Glaucoma and other Lenses
12.6.1.1.5.
Spinal
Implants
12.6.1.1.5.1. Cervical implants
12.6.1.1.5.2. Thoracolumbar implants
12.6.1.1.5.3. Motion preservation implants
12.6.1.1.5.4. Others
12.6.1.1.6.
Others
12.6.1.2.
U.S Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
12.6.1.2.1.
Bioceramics
12.6.1.2.2.
Polymers
12.6.1.2.3.
Natural
polymers
12.6.1.2.4.
Metals
and alloys
12.6.1.2.5.
Others
12.6.1.3.
U.S Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
12.6.1.3.1.
Allograft
12.6.1.3.2.
Synthetic
12.6.1.3.3.
Xenograft
12.6.1.4.
U.S Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
12.6.1.4.1.
Hospitals
and clinics
12.6.1.4.2.
Specialty
clinics
12.6.1.4.3.
Ambulatory
Centers
12.6.1.4.4.
Dental
clinics
12.6.1.4.5.
Others
12.6.2. Canada
12.6.2.1.
Canada Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
12.6.2.1.1.
Cardiovascular
implants
12.6.2.1.1.1. Stents
12.6.2.1.1.2. Pacing devices
12.6.2.1.1.3. Grafts
12.6.2.1.1.4. Structural Cardiac Implants
12.6.2.1.1.4.1. Heart Valves
12.6.2.1.1.4.2. Tissue Heart Valves
12.6.2.1.1.4.3. Implantable Heart Monitors
12.6.2.1.1.4.4. Insertable Loop Recorders
12.6.2.1.1.4.5. Others
12.6.2.1.2.
Orthopedic
Implants and trauma
12.6.2.1.2.1. Knee replacement implants
12.6.2.1.2.2. Hip replacement implants
12.6.2.1.2.3. Ankle replacement implants
12.6.2.1.2.4. Shoulder replacement implants
12.6.2.1.2.5. Others
12.6.2.1.3.
Dental
Implants
12.6.2.1.3.1. Endosteal implants
12.6.2.1.3.2. Subperiosteal implants
12.6.2.1.4.
Ophthalmic
implants
12.6.2.1.4.1. Intraocular lens
12.6.2.1.4.2. Glaucoma and other Lenses
12.6.2.1.5.
Spinal
Implants
12.6.2.1.5.1. Cervical implants
12.6.2.1.5.2. Thoracolumbar implants
12.6.2.1.5.3. Motion preservation implants
12.6.2.1.5.4. Others
12.6.2.1.6.
Others
12.6.2.2.
Canada Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
12.6.2.2.1.
Bioceramics
12.6.2.2.2.
Polymers
12.6.2.2.3.
Natural
polymers
12.6.2.2.4.
Metals
and alloys
12.6.2.2.5.
Others
12.6.2.3.
Canada Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
12.6.2.3.1.
Allograft
12.6.2.3.2.
Synthetic
12.6.2.3.3.
Xenograft
12.6.2.4.
Canada Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
12.6.2.4.1.
Hospitals
and clinics
12.6.2.4.2.
Specialty
clinics
12.6.2.4.3.
Ambulatory
Centers
12.6.2.4.4.
Dental
clinics
12.6.2.4.5.
Others
12.6.3. Mexico
12.6.3.1.
Mexico Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
12.6.3.1.1.
Cardiovascular
implants
12.6.3.1.1.1. Stents
12.6.3.1.1.2. Pacing devices
12.6.3.1.1.3. Grafts
12.6.3.1.1.4. Structural Cardiac Implants
12.6.3.1.1.4.1. Heart Valves
12.6.3.1.1.4.2. Tissue Heart Valves
12.6.3.1.1.4.3. Implantable Heart Monitors
12.6.3.1.1.4.4. Insertable Loop Recorders
12.6.3.1.1.4.5. Others
12.6.3.1.2.
Orthopedic
Implants and trauma
12.6.3.1.2.1. Knee replacement implants
12.6.3.1.2.2. Hip replacement implants
12.6.3.1.2.3. Ankle replacement implants
12.6.3.1.2.4. Shoulder replacement implants
12.6.3.1.2.5. Others
12.6.3.1.3.
Dental
Implants
12.6.3.1.3.1. Endosteal implants
12.6.3.1.3.2. Subperiosteal implants
12.6.3.1.4.
Ophthalmic
implants
12.6.3.1.4.1. Intraocular lens
12.6.3.1.4.2. Glaucoma and other Lenses
12.6.3.1.5.
Spinal
Implants
12.6.3.1.5.1. Cervical implants
12.6.3.1.5.2. Thoracolumbar implants
12.6.3.1.5.3. Motion preservation implants
12.6.3.1.5.4. Others
12.6.3.1.6.
Others
12.6.3.2.
Mexico Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
12.6.3.2.1.
Bioceramics
12.6.3.2.2.
Polymers
12.6.3.2.3.
Natural
polymers
12.6.3.2.4.
Metals
and alloys
12.6.3.2.5.
Others
12.6.3.3.
Mexico Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
12.6.3.3.1.
Allograft
12.6.3.3.2.
Synthetic
12.6.3.3.3.
Xenograft
12.6.3.4.
Mexico Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
12.6.3.4.1.
Hospitals
and clinics
12.6.3.4.2.
Specialty
clinics
12.6.3.4.3.
Ambulatory
Centers
12.6.3.4.4.
Dental
clinics
12.6.3.4.5.
Others
12.6.4. Rest of North America
12.6.4.1.
Rest of
North America Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
12.6.4.1.1.
Cardiovascular
implants
12.6.4.1.1.1. Stents
12.6.4.1.1.2. Pacing devices
12.6.4.1.1.3. Grafts
12.6.4.1.1.4. Structural Cardiac Implants
12.6.4.1.1.4.1. Heart Valves
12.6.4.1.1.4.2. Tissue Heart Valves
12.6.4.1.1.4.3. Implantable Heart Monitors
12.6.4.1.1.4.4. Insertable Loop Recorders
12.6.4.1.1.4.5. Others
12.6.4.1.2.
Orthopedic
Implants and trauma
12.6.4.1.2.1. Knee replacement implants
12.6.4.1.2.2. Hip replacement implants
12.6.4.1.2.3. Ankle replacement implants
12.6.4.1.2.4. Shoulder replacement implants
12.6.4.1.2.5. Others
12.6.4.1.3.
Dental
Implants
12.6.4.1.3.1. Endosteal implants
12.6.4.1.3.2. Subperiosteal implants
12.6.4.1.4.
Ophthalmic
implants
12.6.4.1.4.1. Intraocular lens
12.6.4.1.4.2. Glaucoma and other Lenses
12.6.4.1.5.
Spinal
Implants
12.6.4.1.5.1. Cervical implants
12.6.4.1.5.2. Thoracolumbar implants
12.6.4.1.5.3. Motion preservation implants
12.6.4.1.5.4. Others
12.6.4.1.6.
Others
12.6.4.2.
Rest of
North America Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
12.6.4.2.1.
Bioceramics
12.6.4.2.2.
Polymers
12.6.4.2.3.
Natural
polymers
12.6.4.2.4.
Metals
and alloys
12.6.4.2.5.
Others
12.6.4.3.
Rest of
North America Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
12.6.4.3.1.
Allograft
12.6.4.3.2.
Synthetic
12.6.4.3.3.
Xenograft
12.6.4.4.
Rest of
North America Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
12.6.4.4.1.
Hospitals
and clinics
12.6.4.4.2.
Specialty
clinics
12.6.4.4.3.
Ambulatory
Centers
12.6.4.4.4.
Dental
clinics
12.6.4.4.5.
Others
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Types
12.7.3. By Materials
12.7.4. By Origin
12.7.5. By End users
13. Europe Bio-Implants Market Analysis and
Forecasts, 2022 – 2030
13.1. Overview
13.1.1. Europe Bio-Implants Market Revenue (US$ Mn)
13.2. Europe Bio-Implants Market Revenue (US$ Mn)
and Forecasts, By Types
13.2.1. Cardiovascular implants
13.2.1.1.
Stents
13.2.1.2.
Pacing
devices
13.2.1.3.
Grafts
13.2.1.4.
Structural
Cardiac Implants
13.2.1.4.1.
Heart
Valves
13.2.1.4.2.
Tissue
Heart Valves
13.2.1.4.3.
Implantable
Heart Monitors
13.2.1.4.4.
Insertable
Loop Recorders
13.2.1.4.5.
Others
13.2.2. Orthopedic Implants and trauma
13.2.2.1.
Knee
replacement implants
13.2.2.2.
Hip
replacement implants
13.2.2.3.
Ankle
replacement implants
13.2.2.4.
Shoulder
replacement implants
13.2.2.5.
Others
13.2.3. Dental Implants
13.2.3.1.
Endosteal
implants
13.2.3.2.
Subperiosteal
implants
13.2.4. Ophthalmic implants
13.2.4.1.
Intraocular
lens
13.2.4.2.
Glaucoma
and other Lenses
13.2.5. Spinal Implants
13.2.5.1.
Cervical
implants
13.2.5.2.
Thoracolumbar
implants
13.2.5.3.
Motion
preservation implants
13.2.5.4.
Others
13.2.6. Others
13.3. Europe Bio-Implants Market Revenue (US$ Mn)
and Forecasts, By Materials
13.3.1. Bioceramics
13.3.2. Polymers
13.3.3. Natural polymers
13.3.4. Metals and alloys
13.3.5. Others
13.4. Europe Bio-Implants Market Revenue (US$ Mn)
and Forecasts, By Origin
13.4.1. Allograft
13.4.2. Synthetic
13.4.3. Xenograft
13.5. Europe Bio-Implants Market Revenue (US$ Mn)
and Forecasts, By End users
13.5.1. Hospitals and clinics
13.5.2. Specialty clinics
13.5.3. Ambulatory Centers
13.5.4. Dental clinics
13.5.5. Others
13.6. Europe Bio-Implants Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.1. France
13.6.1.1.
France Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
13.6.1.1.1.
Cardiovascular
implants
13.6.1.1.1.1. Stents
13.6.1.1.1.2. Pacing devices
13.6.1.1.1.3. Grafts
13.6.1.1.1.4. Structural Cardiac Implants
13.6.1.1.1.4.1. Heart Valves
13.6.1.1.1.4.2. Tissue Heart Valves
13.6.1.1.1.4.3. Implantable Heart Monitors
13.6.1.1.1.4.4. Insertable Loop Recorders
13.6.1.1.1.4.5. Others
13.6.1.1.2.
Orthopedic
Implants and trauma
13.6.1.1.2.1. Knee replacement implants
13.6.1.1.2.2. Hip replacement implants
13.6.1.1.2.3. Ankle replacement implants
13.6.1.1.2.4. Shoulder replacement implants
13.6.1.1.2.5. Others
13.6.1.1.3.
Dental
Implants
13.6.1.1.3.1. Endosteal implants
13.6.1.1.3.2. Subperiosteal implants
13.6.1.1.4.
Ophthalmic
implants
13.6.1.1.4.1. Intraocular lens
13.6.1.1.4.2. Glaucoma and other Lenses
13.6.1.1.5.
Spinal
Implants
13.6.1.1.5.1. Cervical implants
13.6.1.1.5.2. Thoracolumbar implants
13.6.1.1.5.3. Motion preservation implants
13.6.1.1.5.4. Others
13.6.1.1.6.
Others
13.6.1.2.
France Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
13.6.1.2.1.
Bioceramics
13.6.1.2.2.
Polymers
13.6.1.2.3.
Natural
polymers
13.6.1.2.4.
Metals
and alloys
13.6.1.2.5.
Others
13.6.1.3.
France Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
13.6.1.3.1.
Allograft
13.6.1.3.2.
Synthetic
13.6.1.3.3.
Xenograft
13.6.1.4.
France Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
13.6.1.4.1.
Hospitals
and clinics
13.6.1.4.2.
Specialty
clinics
13.6.1.4.3.
Ambulatory
Centers
13.6.1.4.4.
Dental
clinics
13.6.1.4.5.
Others
13.6.2. The UK
13.6.2.1.
The UK Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
13.6.2.1.1.
Cardiovascular
implants
13.6.2.1.1.1. Stents
13.6.2.1.1.2. Pacing devices
13.6.2.1.1.3. Grafts
13.6.2.1.1.4. Structural Cardiac Implants
13.6.2.1.1.4.1. Heart Valves
13.6.2.1.1.4.2. Tissue Heart Valves
13.6.2.1.1.4.3. Implantable Heart Monitors
13.6.2.1.1.4.4. Insertable Loop Recorders
13.6.2.1.1.4.5. Others
13.6.2.1.2.
Orthopedic
Implants and trauma
13.6.2.1.2.1. Knee replacement implants
13.6.2.1.2.2. Hip replacement implants
13.6.2.1.2.3. Ankle replacement implants
13.6.2.1.2.4. Shoulder replacement implants
13.6.2.1.2.5. Others
13.6.2.1.3.
Dental
Implants
13.6.2.1.3.1. Endosteal implants
13.6.2.1.3.2. Subperiosteal implants
13.6.2.1.4.
Ophthalmic
implants
13.6.2.1.4.1. Intraocular lens
13.6.2.1.4.2. Glaucoma and other Lenses
13.6.2.1.5.
Spinal
Implants
13.6.2.1.5.1. Cervical implants
13.6.2.1.5.2. Thoracolumbar implants
13.6.2.1.5.3. Motion preservation implants
13.6.2.1.5.4. Others
13.6.2.1.6.
Others
13.6.2.2.
The UK Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
13.6.2.2.1.
Bioceramics
13.6.2.2.2.
Polymers
13.6.2.2.3.
Natural
polymers
13.6.2.2.4.
Metals
and alloys
13.6.2.2.5.
Others
13.6.2.3.
The UK Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
13.6.2.3.1.
Allograft
13.6.2.3.2.
Synthetic
13.6.2.3.3.
Xenograft
13.6.2.4.
The UK Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
13.6.2.4.1.
Hospitals
and clinics
13.6.2.4.2.
Specialty
clinics
13.6.2.4.3.
Ambulatory
Centers
13.6.2.4.4.
Dental
clinics
13.6.2.4.5.
Others
13.6.3. Spain
13.6.3.1.
Spain Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
13.6.3.1.1.
Cardiovascular
implants
13.6.3.1.1.1. Stents
13.6.3.1.1.2. Pacing devices
13.6.3.1.1.3. Grafts
13.6.3.1.1.4. Structural Cardiac Implants
13.6.3.1.1.4.1. Heart Valves
13.6.3.1.1.4.2. Tissue Heart Valves
13.6.3.1.1.4.3. Implantable Heart Monitors
13.6.3.1.1.4.4. Insertable Loop Recorders
13.6.3.1.1.4.5. Others
13.6.3.1.2.
Orthopedic
Implants and trauma
13.6.3.1.2.1. Knee replacement implants
13.6.3.1.2.2. Hip replacement implants
13.6.3.1.2.3. Ankle replacement implants
13.6.3.1.2.4. Shoulder replacement implants
13.6.3.1.2.5. Others
13.6.3.1.3.
Dental
Implants
13.6.3.1.3.1. Endosteal implants
13.6.3.1.3.2. Subperiosteal implants
13.6.3.1.4.
Ophthalmic
implants
13.6.3.1.4.1. Intraocular lens
13.6.3.1.4.2. Glaucoma and other Lenses
13.6.3.1.5.
Spinal
Implants
13.6.3.1.5.1. Cervical implants
13.6.3.1.5.2. Thoracolumbar implants
13.6.3.1.5.3. Motion preservation implants
13.6.3.1.5.4. Others
13.6.3.1.6.
Others
13.6.3.2.
Spain Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
13.6.3.2.1.
Bioceramics
13.6.3.2.2.
Polymers
13.6.3.2.3.
Natural
polymers
13.6.3.2.4.
Metals
and alloys
13.6.3.2.5.
Others
13.6.3.3.
Spain Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
13.6.3.3.1.
Allograft
13.6.3.3.2.
Synthetic
13.6.3.3.3.
Xenograft
13.6.3.4.
Spain Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
13.6.3.4.1.
Hospitals
and clinics
13.6.3.4.2.
Specialty
clinics
13.6.3.4.3.
Ambulatory
Centers
13.6.3.4.4.
Dental
clinics
13.6.3.4.5.
Others
13.6.4. Germany
13.6.4.1.
Germany Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
13.6.4.1.1.
Cardiovascular
implants
13.6.4.1.1.1. Stents
13.6.4.1.1.2. Pacing devices
13.6.4.1.1.3. Grafts
13.6.4.1.1.4. Structural Cardiac Implants
13.6.4.1.1.4.1. Heart Valves
13.6.4.1.1.4.2. Tissue Heart Valves
13.6.4.1.1.4.3. Implantable Heart Monitors
13.6.4.1.1.4.4. Insertable Loop Recorders
13.6.4.1.1.4.5. Others
13.6.4.1.2.
Orthopedic
Implants and trauma
13.6.4.1.2.1. Knee replacement implants
13.6.4.1.2.2. Hip replacement implants
13.6.4.1.2.3. Ankle replacement implants
13.6.4.1.2.4. Shoulder replacement implants
13.6.4.1.2.5. Others
13.6.4.1.3.
Dental
Implants
13.6.4.1.3.1. Endosteal implants
13.6.4.1.3.2. Subperiosteal implants
13.6.4.1.4.
Ophthalmic
implants
13.6.4.1.4.1. Intraocular lens
13.6.4.1.4.2. Glaucoma and other Lenses
13.6.4.1.5.
Spinal
Implants
13.6.4.1.5.1. Cervical implants
13.6.4.1.5.2. Thoracolumbar implants
13.6.4.1.5.3. Motion preservation implants
13.6.4.1.5.4. Others
13.6.4.1.6.
Others
13.6.4.2.
Germany Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
13.6.4.2.1.
Bioceramics
13.6.4.2.2.
Polymers
13.6.4.2.3.
Natural
polymers
13.6.4.2.4.
Metals
and alloys
13.6.4.2.5.
Others
13.6.4.3.
Germany Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
13.6.4.3.1.
Allograft
13.6.4.3.2.
Synthetic
13.6.4.3.3.
Xenograft
13.6.4.4.
Germany Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
13.6.4.4.1.
Hospitals
and clinics
13.6.4.4.2.
Specialty
clinics
13.6.4.4.3.
Ambulatory
Centers
13.6.4.4.4.
Dental
clinics
13.6.4.4.5.
Others
13.6.5. Italy
13.6.5.1.
Italy Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
13.6.5.1.1.
Cardiovascular
implants
13.6.5.1.1.1. Stents
13.6.5.1.1.2. Pacing devices
13.6.5.1.1.3. Grafts
13.6.5.1.1.4. Structural Cardiac Implants
13.6.5.1.1.4.1. Heart Valves
13.6.5.1.1.4.2. Tissue Heart Valves
13.6.5.1.1.4.3. Implantable Heart Monitors
13.6.5.1.1.4.4. Insertable Loop Recorders
13.6.5.1.1.4.5. Others
13.6.5.1.2.
Orthopedic
Implants and trauma
13.6.5.1.2.1. Knee replacement implants
13.6.5.1.2.2. Hip replacement implants
13.6.5.1.2.3. Ankle replacement implants
13.6.5.1.2.4. Shoulder replacement implants
13.6.5.1.2.5. Others
13.6.5.1.3.
Dental
Implants
13.6.5.1.3.1. Endosteal implants
13.6.5.1.3.2. Subperiosteal implants
13.6.5.1.4.
Ophthalmic
implants
13.6.5.1.4.1. Intraocular lens
13.6.5.1.4.2. Glaucoma and other Lenses
13.6.5.1.5.
Spinal
Implants
13.6.5.1.5.1. Cervical implants
13.6.5.1.5.2. Thoracolumbar implants
13.6.5.1.5.3. Motion preservation implants
13.6.5.1.5.4. Others
13.6.5.1.6.
Others
13.6.5.2.
Italy Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
13.6.5.2.1.
Bioceramics
13.6.5.2.2.
Polymers
13.6.5.2.3.
Natural
polymers
13.6.5.2.4.
Metals
and alloys
13.6.5.2.5.
Others
13.6.5.3.
Italy Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
13.6.5.3.1.
Allograft
13.6.5.3.2.
Synthetic
13.6.5.3.3.
Xenograft
13.6.5.4.
Italy Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
13.6.5.4.1.
Hospitals
and clinics
13.6.5.4.2.
Specialty
clinics
13.6.5.4.3.
Ambulatory
Centers
13.6.5.4.4.
Dental
clinics
13.6.5.4.5.
Others
13.6.6. Nordic Countries
13.6.6.1.
Nordic
Countries Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
13.6.6.1.1.
Cardiovascular
implants
13.6.6.1.1.1. Stents
13.6.6.1.1.2. Pacing devices
13.6.6.1.1.3. Grafts
13.6.6.1.1.4. Structural Cardiac Implants
13.6.6.1.1.4.1. Heart Valves
13.6.6.1.1.4.2. Tissue Heart Valves
13.6.6.1.1.4.3. Implantable Heart Monitors
13.6.6.1.1.4.4. Insertable Loop Recorders
13.6.6.1.1.4.5. Others
13.6.6.1.2.
Orthopedic
Implants and trauma
13.6.6.1.2.1. Knee replacement implants
13.6.6.1.2.2. Hip replacement implants
13.6.6.1.2.3. Ankle replacement implants
13.6.6.1.2.4. Shoulder replacement implants
13.6.6.1.2.5. Others
13.6.6.1.3.
Dental
Implants
13.6.6.1.3.1. Endosteal implants
13.6.6.1.3.2. Subperiosteal implants
13.6.6.1.4.
Ophthalmic
implants
13.6.6.1.4.1. Intraocular lens
13.6.6.1.4.2. Glaucoma and other Lenses
13.6.6.1.5.
Spinal
Implants
13.6.6.1.5.1. Cervical implants
13.6.6.1.5.2. Thoracolumbar implants
13.6.6.1.5.3. Motion preservation implants
13.6.6.1.5.4. Others
13.6.6.1.6.
Others
13.6.6.2.
Nordic
Countries Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
13.6.6.2.1.
Bioceramics
13.6.6.2.2.
Polymers
13.6.6.2.3.
Natural
polymers
13.6.6.2.4.
Metals
and alloys
13.6.6.2.5.
Others
13.6.6.3.
Nordic
Countries Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
13.6.6.3.1.
Allograft
13.6.6.3.2.
Synthetic
13.6.6.3.3.
Xenograft
13.6.6.4.
Nordic
Countries Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
13.6.6.4.1.
Hospitals
and clinics
13.6.6.4.2.
Specialty
clinics
13.6.6.4.3.
Ambulatory
Centers
13.6.6.4.4.
Dental
clinics
13.6.6.4.5.
Others
13.6.6.5.
Nordic
Countries Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1.
Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4.
Sweden
13.6.6.5.5.
Norway
13.6.7. Benelux Union
13.6.7.1.
Benelux
Union Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
13.6.7.1.1.
Cardiovascular
implants
13.6.7.1.1.1. Stents
13.6.7.1.1.2. Pacing devices
13.6.7.1.1.3. Grafts
13.6.7.1.1.4. Structural Cardiac Implants
13.6.7.1.1.4.1. Heart Valves
13.6.7.1.1.4.2. Tissue Heart Valves
13.6.7.1.1.4.3. Implantable Heart Monitors
13.6.7.1.1.4.4. Insertable Loop Recorders
13.6.7.1.1.4.5. Others
13.6.7.1.2.
Orthopedic
Implants and trauma
13.6.7.1.2.1. Knee replacement implants
13.6.7.1.2.2. Hip replacement implants
13.6.7.1.2.3. Ankle replacement implants
13.6.7.1.2.4. Shoulder replacement implants
13.6.7.1.2.5. Others
13.6.7.1.3.
Dental
Implants
13.6.7.1.3.1. Endosteal implants
13.6.7.1.3.2. Subperiosteal implants
13.6.7.1.4.
Ophthalmic
implants
13.6.7.1.4.1. Intraocular lens
13.6.7.1.4.2. Glaucoma and other Lenses
13.6.7.1.5.
Spinal
Implants
13.6.7.1.5.1. Cervical implants
13.6.7.1.5.2. Thoracolumbar implants
13.6.7.1.5.3. Motion preservation implants
13.6.7.1.5.4. Others
13.6.7.1.6.
Others
13.6.7.2.
Benelux
Union Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
13.6.7.2.1.
Bioceramics
13.6.7.2.2.
Polymers
13.6.7.2.3.
Natural
polymers
13.6.7.2.4.
Metals
and alloys
13.6.7.2.5.
Others
13.6.7.3.
Benelux
Union Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
13.6.7.3.1.
Allograft
13.6.7.3.2.
Synthetic
13.6.7.3.3.
Xenograft
13.6.7.4.
Benelux
Union Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
13.6.7.4.1.
Hospitals
and clinics
13.6.7.4.2.
Specialty
clinics
13.6.7.4.3.
Ambulatory
Centers
13.6.7.4.4.
Dental
clinics
13.6.7.4.5.
Others
13.6.7.5.
Benelux
Union Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
The
Netherlands
13.6.7.5.3.
Luxembourg
13.6.8. Rest of Europe
13.6.8.1.
Rest of
Europe Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
13.6.8.1.1.
Cardiovascular
implants
13.6.8.1.1.1. Stents
13.6.8.1.1.2. Pacing devices
13.6.8.1.1.3. Grafts
13.6.8.1.1.4. Structural Cardiac Implants
13.6.8.1.1.4.1. Heart Valves
13.6.8.1.1.4.2. Tissue Heart Valves
13.6.8.1.1.4.3. Implantable Heart Monitors
13.6.8.1.1.4.4. Insertable Loop Recorders
13.6.8.1.1.4.5. Others
13.6.8.1.2.
Orthopedic
Implants and trauma
13.6.8.1.2.1. Knee replacement implants
13.6.8.1.2.2. Hip replacement implants
13.6.8.1.2.3. Ankle replacement implants
13.6.8.1.2.4. Shoulder replacement implants
13.6.8.1.2.5. Others
13.6.8.1.3.
Dental
Implants
13.6.8.1.3.1. Endosteal implants
13.6.8.1.3.2. Subperiosteal implants
13.6.8.1.4.
Ophthalmic
implants
13.6.8.1.4.1. Intraocular lens
13.6.8.1.4.2. Glaucoma and other Lenses
13.6.8.1.5.
Spinal
Implants
13.6.8.1.5.1. Cervical implants
13.6.8.1.5.2. Thoracolumbar implants
13.6.8.1.5.3. Motion preservation implants
13.6.8.1.5.4. Others
13.6.8.1.6.
Others
13.6.8.2.
Rest of
Europe Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
13.6.8.2.1.
Bioceramics
13.6.8.2.2.
Polymers
13.6.8.2.3.
Natural
polymers
13.6.8.2.4.
Metals
and alloys
13.6.8.2.5.
Others
13.6.8.3.
Rest of
Europe Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
13.6.8.3.1.
Allograft
13.6.8.3.2.
Synthetic
13.6.8.3.3.
Xenograft
13.6.8.4.
Rest of
Europe Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
13.6.8.4.1.
Hospitals
and clinics
13.6.8.4.2.
Specialty
clinics
13.6.8.4.3.
Ambulatory
Centers
13.6.8.4.4.
Dental
clinics
13.6.8.4.5.
Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Types
13.7.3. By Materials
13.7.4. By Origin
13.7.5. By End users
14. Asia Pacific Bio-Implants Market Analysis
and Forecasts, 2022 – 2030
14.1. Overview
14.1.1. Asia Pacific Bio-Implants Market Revenue (US$
Mn)
14.2. Asia Pacific Bio-Implants Market Revenue (US$
Mn) and Forecasts, By Types
14.2.1. Cardiovascular implants
14.2.1.1.
Stents
14.2.1.2.
Pacing
devices
14.2.1.3.
Grafts
14.2.1.4.
Structural
Cardiac Implants
14.2.1.4.1.
Heart
Valves
14.2.1.4.2.
Tissue
Heart Valves
14.2.1.4.3.
Implantable
Heart Monitors
14.2.1.4.4.
Insertable
Loop Recorders
14.2.1.4.5.
Others
14.2.2. Orthopedic Implants and trauma
14.2.2.1.
Knee
replacement implants
14.2.2.2.
Hip
replacement implants
14.2.2.3.
Ankle
replacement implants
14.2.2.4.
Shoulder
replacement implants
14.2.2.5.
Others
14.2.3. Dental Implants
14.2.3.1.
Endosteal
implants
14.2.3.2.
Subperiosteal
implants
14.2.4. Ophthalmic implants
14.2.4.1.
Intraocular
lens
14.2.4.2.
Glaucoma
and other Lenses
14.2.5. Spinal Implants
14.2.5.1.
Cervical
implants
14.2.5.2.
Thoracolumbar
implants
14.2.5.3.
Motion
preservation implants
14.2.5.4.
Others
14.2.6. Others
14.3. Asia Pacific Bio-Implants Market Revenue (US$
Mn) and Forecasts, By Materials
14.3.1. Bioceramics
14.3.2. Polymers
14.3.3. Natural polymers
14.3.4. Metals and alloys
14.3.5. Others
14.4. Asia Pacific Bio-Implants Market Revenue (US$
Mn) and Forecasts, By Origin
14.4.1. Allograft
14.4.2. Synthetic
14.4.3. Xenograft
14.5. Asia Pacific Bio-Implants Market Revenue (US$
Mn) and Forecasts, By End users
14.5.1. Hospitals and clinics
14.5.2. Specialty clinics
14.5.3. Ambulatory Centers
14.5.4. Dental clinics
14.5.5. Others
14.6. Asia Pacific Bio-Implants Market Revenue (US$
Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1.
China Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
14.6.1.1.1.
Cardiovascular
implants
14.6.1.1.1.1. Stents
14.6.1.1.1.2. Pacing devices
14.6.1.1.1.3. Grafts
14.6.1.1.1.4. Structural Cardiac Implants
14.6.1.1.1.4.1. Heart Valves
14.6.1.1.1.4.2. Tissue Heart Valves
14.6.1.1.1.4.3. Implantable Heart Monitors
14.6.1.1.1.4.4. Insertable Loop Recorders
14.6.1.1.1.4.5. Others
14.6.1.1.2.
Orthopedic
Implants and trauma
14.6.1.1.2.1. Knee replacement implants
14.6.1.1.2.2. Hip replacement implants
14.6.1.1.2.3. Ankle replacement implants
14.6.1.1.2.4. Shoulder replacement implants
14.6.1.1.2.5. Others
14.6.1.1.3.
Dental
Implants
14.6.1.1.3.1. Endosteal implants
14.6.1.1.3.2. Subperiosteal implants
14.6.1.1.4.
Ophthalmic
implants
14.6.1.1.4.1. Intraocular lens
14.6.1.1.4.2. Glaucoma and other Lenses
14.6.1.1.5.
Spinal
Implants
14.6.1.1.5.1. Cervical implants
14.6.1.1.5.2. Thoracolumbar implants
14.6.1.1.5.3. Motion preservation implants
14.6.1.1.5.4. Others
14.6.1.1.6.
Others
14.6.1.2.
China Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
14.6.1.2.1.
Bioceramics
14.6.1.2.2.
Polymers
14.6.1.2.3.
Natural
polymers
14.6.1.2.4.
Metals
and alloys
14.6.1.2.5.
Others
14.6.1.3.
China Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
14.6.1.3.1.
Allograft
14.6.1.3.2.
Synthetic
14.6.1.3.3.
Xenograft
14.6.1.4.
China Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
14.6.1.4.1.
Hospitals
and clinics
14.6.1.4.2.
Specialty
clinics
14.6.1.4.3.
Ambulatory
Centers
14.6.1.4.4.
Dental
clinics
14.6.1.4.5.
Others
14.6.2. Japan
14.6.2.1.
Japan Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
14.6.2.1.1.
Cardiovascular
implants
14.6.2.1.1.1. Stents
14.6.2.1.1.2. Pacing devices
14.6.2.1.1.3. Grafts
14.6.2.1.1.4. Structural Cardiac Implants
14.6.2.1.1.4.1. Heart Valves
14.6.2.1.1.4.2. Tissue Heart Valves
14.6.2.1.1.4.3. Implantable Heart Monitors
14.6.2.1.1.4.4. Insertable Loop Recorders
14.6.2.1.1.4.5. Others
14.6.2.1.2.
Orthopedic
Implants and trauma
14.6.2.1.2.1. Knee replacement implants
14.6.2.1.2.2. Hip replacement implants
14.6.2.1.2.3. Ankle replacement implants
14.6.2.1.2.4. Shoulder replacement implants
14.6.2.1.2.5. Others
14.6.2.1.3.
Dental
Implants
14.6.2.1.3.1. Endosteal implants
14.6.2.1.3.2. Subperiosteal implants
14.6.2.1.4.
Ophthalmic
implants
14.6.2.1.4.1. Intraocular lens
14.6.2.1.4.2. Glaucoma and other Lenses
14.6.2.1.5.
Spinal
Implants
14.6.2.1.5.1. Cervical implants
14.6.2.1.5.2. Thoracolumbar implants
14.6.2.1.5.3. Motion preservation implants
14.6.2.1.5.4. Others
14.6.2.1.6.
Others
14.6.2.2.
Japan Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
14.6.2.2.1.
Bioceramics
14.6.2.2.2.
Polymers
14.6.2.2.3.
Natural
polymers
14.6.2.2.4.
Metals
and alloys
14.6.2.2.5.
Others
14.6.2.3.
Japan Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
14.6.2.3.1.
Allograft
14.6.2.3.2.
Synthetic
14.6.2.3.3.
Xenograft
14.6.2.4.
Japan Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
14.6.2.4.1.
Hospitals
and clinics
14.6.2.4.2.
Specialty
clinics
14.6.2.4.3.
Ambulatory
Centers
14.6.2.4.4.
Dental clinics
14.6.2.4.5.
Others
14.6.3. India
14.6.3.1.
India Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
14.6.3.1.1.
Cardiovascular
implants
14.6.3.1.1.1. Stents
14.6.3.1.1.2. Pacing devices
14.6.3.1.1.3. Grafts
14.6.3.1.1.4. Structural Cardiac Implants
14.6.3.1.1.4.1. Heart Valves
14.6.3.1.1.4.2. Tissue Heart Valves
14.6.3.1.1.4.3. Implantable Heart Monitors
14.6.3.1.1.4.4. Insertable Loop Recorders
14.6.3.1.1.4.5. Others
14.6.3.1.2.
Orthopedic
Implants and trauma
14.6.3.1.2.1. Knee replacement implants
14.6.3.1.2.2. Hip replacement implants
14.6.3.1.2.3. Ankle replacement implants
14.6.3.1.2.4. Shoulder replacement implants
14.6.3.1.2.5. Others
14.6.3.1.3.
Dental
Implants
14.6.3.1.3.1. Endosteal implants
14.6.3.1.3.2. Subperiosteal implants
14.6.3.1.4.
Ophthalmic
implants
14.6.3.1.4.1. Intraocular lens
14.6.3.1.4.2. Glaucoma and other Lenses
14.6.3.1.5.
Spinal
Implants
14.6.3.1.5.1. Cervical implants
14.6.3.1.5.2. Thoracolumbar implants
14.6.3.1.5.3. Motion preservation implants
14.6.3.1.5.4. Others
14.6.3.1.6.
Others
14.6.3.2.
India Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
14.6.3.2.1.
Bioceramics
14.6.3.2.2.
Polymers
14.6.3.2.3.
Natural
polymers
14.6.3.2.4.
Metals
and alloys
14.6.3.2.5.
Others
14.6.3.3.
India Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
14.6.3.3.1.
Allograft
14.6.3.3.2.
Synthetic
14.6.3.3.3.
Xenograft
14.6.3.4.
India Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
14.6.3.4.1.
Hospitals
and clinics
14.6.3.4.2.
Specialty
clinics
14.6.3.4.3.
Ambulatory
Centers
14.6.3.4.4.
Dental
clinics
14.6.3.4.5.
Others
14.6.4. New Zealand
14.6.4.1.
New
Zealand Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
14.6.4.1.1.
Cardiovascular
implants
14.6.4.1.1.1. Stents
14.6.4.1.1.2. Pacing devices
14.6.4.1.1.3. Grafts
14.6.4.1.1.4. Structural Cardiac Implants
14.6.4.1.1.4.1. Heart Valves
14.6.4.1.1.4.2. Tissue Heart Valves
14.6.4.1.1.4.3. Implantable Heart Monitors
14.6.4.1.1.4.4. Insertable Loop Recorders
14.6.4.1.1.4.5. Others
14.6.4.1.2.
Orthopedic
Implants and trauma
14.6.4.1.2.1. Knee replacement implants
14.6.4.1.2.2. Hip replacement implants
14.6.4.1.2.3. Ankle replacement implants
14.6.4.1.2.4. Shoulder replacement implants
14.6.4.1.2.5. Others
14.6.4.1.3.
Dental
Implants
14.6.4.1.3.1. Endosteal implants
14.6.4.1.3.2. Subperiosteal implants
14.6.4.1.4.
Ophthalmic
implants
14.6.4.1.4.1. Intraocular lens
14.6.4.1.4.2. Glaucoma and other Lenses
14.6.4.1.5.
Spinal
Implants
14.6.4.1.5.1. Cervical implants
14.6.4.1.5.2. Thoracolumbar implants
14.6.4.1.5.3. Motion preservation implants
14.6.4.1.5.4. Others
14.6.4.1.6.
Others
14.6.4.2.
New
Zealand Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
14.6.4.2.1.
Bioceramics
14.6.4.2.2.
Polymers
14.6.4.2.3.
Natural
polymers
14.6.4.2.4.
Metals
and alloys
14.6.4.2.5.
Others
14.6.4.3.
New
Zealand Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
14.6.4.3.1.
Allograft
14.6.4.3.2.
Synthetic
14.6.4.3.3.
Xenograft
14.6.4.4.
New
Zealand Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
14.6.4.4.1.
Hospitals
and clinics
14.6.4.4.2.
Specialty
clinics
14.6.4.4.3.
Ambulatory
Centers
14.6.4.4.4.
Dental
clinics
14.6.4.4.5.
Others
14.6.5. Australia
14.6.5.1.
Australia
Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
14.6.5.1.1.
Cardiovascular
implants
14.6.5.1.1.1. Stents
14.6.5.1.1.2. Pacing devices
14.6.5.1.1.3. Grafts
14.6.5.1.1.4. Structural Cardiac Implants
14.6.5.1.1.4.1. Heart Valves
14.6.5.1.1.4.2. Tissue Heart Valves
14.6.5.1.1.4.3. Implantable Heart Monitors
14.6.5.1.1.4.4. Insertable Loop Recorders
14.6.5.1.1.4.5. Others
14.6.5.1.2.
Orthopedic
Implants and trauma
14.6.5.1.2.1. Knee replacement implants
14.6.5.1.2.2. Hip replacement implants
14.6.5.1.2.3. Ankle replacement implants
14.6.5.1.2.4. Shoulder replacement implants
14.6.5.1.2.5. Others
14.6.5.1.3.
Dental
Implants
14.6.5.1.3.1. Endosteal implants
14.6.5.1.3.2. Subperiosteal implants
14.6.5.1.4.
Ophthalmic
implants
14.6.5.1.4.1. Intraocular lens
14.6.5.1.4.2. Glaucoma and other Lenses
14.6.5.1.5.
Spinal
Implants
14.6.5.1.5.1. Cervical implants
14.6.5.1.5.2. Thoracolumbar implants
14.6.5.1.5.3. Motion preservation implants
14.6.5.1.5.4. Others
14.6.5.1.6.
Others
14.6.5.2.
Australia
Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
14.6.5.2.1.
Bioceramics
14.6.5.2.2.
Polymers
14.6.5.2.3.
Natural
polymers
14.6.5.2.4.
Metals
and alloys
14.6.5.2.5.
Others
14.6.5.3.
Australia
Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
14.6.5.3.1.
Allograft
14.6.5.3.2.
Synthetic
14.6.5.3.3.
Xenograft
14.6.5.4.
Australia
Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
14.6.5.4.1.
Hospitals
and clinics
14.6.5.4.2.
Specialty
clinics
14.6.5.4.3.
Ambulatory
Centers
14.6.5.4.4.
Dental
clinics
14.6.5.4.5.
Others
14.6.6. South Korea
14.6.6.1.
South
Korea Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
14.6.6.1.1.
Cardiovascular
implants
14.6.6.1.1.1. Stents
14.6.6.1.1.2. Pacing devices
14.6.6.1.1.3. Grafts
14.6.6.1.1.4. Structural Cardiac Implants
14.6.6.1.1.4.1. Heart Valves
14.6.6.1.1.4.2. Tissue Heart Valves
14.6.6.1.1.4.3. Implantable Heart Monitors
14.6.6.1.1.4.4. Insertable Loop Recorders
14.6.6.1.1.4.5. Others
14.6.6.1.2.
Orthopedic
Implants and trauma
14.6.6.1.2.1. Knee replacement implants
14.6.6.1.2.2. Hip replacement implants
14.6.6.1.2.3. Ankle replacement implants
14.6.6.1.2.4. Shoulder replacement implants
14.6.6.1.2.5. Others
14.6.6.1.3.
Dental
Implants
14.6.6.1.3.1. Endosteal implants
14.6.6.1.3.2. Subperiosteal implants
14.6.6.1.4.
Ophthalmic
implants
14.6.6.1.4.1. Intraocular lens
14.6.6.1.4.2. Glaucoma and other Lenses
14.6.6.1.5.
Spinal
Implants
14.6.6.1.5.1. Cervical implants
14.6.6.1.5.2. Thoracolumbar implants
14.6.6.1.5.3. Motion preservation implants
14.6.6.1.5.4. Others
14.6.6.1.6.
Others
14.6.6.2.
South
Korea Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
14.6.6.2.1.
Bioceramics
14.6.6.2.2.
Polymers
14.6.6.2.3.
Natural
polymers
14.6.6.2.4.
Metals
and alloys
14.6.6.2.5.
Others
14.6.6.3.
South
Korea Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
14.6.6.3.1.
Allograft
14.6.6.3.2.
Synthetic
14.6.6.3.3.
Xenograft
14.6.6.4.
South
Korea Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
14.6.6.4.1.
Hospitals
and clinics
14.6.6.4.2.
Specialty
clinics
14.6.6.4.3.
Ambulatory
Centers
14.6.6.4.4.
Dental
clinics
14.6.6.4.5.
Others
14.6.7. Southeast Asia
14.6.7.1.
Southeast
Asia Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
14.6.7.1.1.
Cardiovascular
implants
14.6.7.1.1.1. Stents
14.6.7.1.1.2. Pacing devices
14.6.7.1.1.3. Grafts
14.6.7.1.1.4. Structural Cardiac Implants
14.6.7.1.1.4.1. Heart Valves
14.6.7.1.1.4.2. Tissue Heart Valves
14.6.7.1.1.4.3. Implantable Heart Monitors
14.6.7.1.1.4.4. Insertable Loop Recorders
14.6.7.1.1.4.5. Others
14.6.7.1.2.
Orthopedic
Implants and trauma
14.6.7.1.2.1. Knee replacement implants
14.6.7.1.2.2. Hip replacement implants
14.6.7.1.2.3. Ankle replacement implants
14.6.7.1.2.4. Shoulder replacement implants
14.6.7.1.2.5. Others
14.6.7.1.3.
Dental
Implants
14.6.7.1.3.1. Endosteal implants
14.6.7.1.3.2. Subperiosteal implants
14.6.7.1.4.
Ophthalmic
implants
14.6.7.1.4.1. Intraocular lens
14.6.7.1.4.2. Glaucoma and other Lenses
14.6.7.1.5.
Spinal
Implants
14.6.7.1.5.1. Cervical implants
14.6.7.1.5.2. Thoracolumbar implants
14.6.7.1.5.3. Motion preservation implants
14.6.7.1.5.4. Others
14.6.7.1.6.
Others
14.6.7.2.
Southeast
Asia Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
14.6.7.2.1.
Bioceramics
14.6.7.2.2.
Polymers
14.6.7.2.3.
Natural
polymers
14.6.7.2.4.
Metals
and alloys
14.6.7.2.5.
Others
14.6.7.3.
Southeast
Asia Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
14.6.7.3.1.
Allograft
14.6.7.3.2.
Synthetic
14.6.7.3.3.
Xenograft
14.6.7.4.
Southeast
Asia Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
14.6.7.4.1.
Hospitals
and clinics
14.6.7.4.2.
Specialty
clinics
14.6.7.4.3.
Ambulatory
Centers
14.6.7.4.4.
Dental
clinics
14.6.7.4.5.
Others
14.6.7.5.
Southeast
Asia Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1.
Indonesia
14.6.7.5.2.
Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of
Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1.
Rest of
Asia Pacific Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
14.6.8.1.1.
Cardiovascular
implants
14.6.8.1.1.1. Stents
14.6.8.1.1.2. Pacing devices
14.6.8.1.1.3. Grafts
14.6.8.1.1.4. Structural Cardiac Implants
14.6.8.1.1.4.1. Heart Valves
14.6.8.1.1.4.2. Tissue Heart Valves
14.6.8.1.1.4.3. Implantable Heart Monitors
14.6.8.1.1.4.4. Insertable Loop Recorders
14.6.8.1.1.4.5. Others
14.6.8.1.2.
Orthopedic
Implants and trauma
14.6.8.1.2.1. Knee replacement implants
14.6.8.1.2.2. Hip replacement implants
14.6.8.1.2.3. Ankle replacement implants
14.6.8.1.2.4. Shoulder replacement implants
14.6.8.1.2.5. Others
14.6.8.1.3.
Dental
Implants
14.6.8.1.3.1. Endosteal implants
14.6.8.1.3.2. Subperiosteal implants
14.6.8.1.4.
Ophthalmic
implants
14.6.8.1.4.1. Intraocular lens
14.6.8.1.4.2. Glaucoma and other Lenses
14.6.8.1.5.
Spinal
Implants
14.6.8.1.5.1. Cervical implants
14.6.8.1.5.2. Thoracolumbar implants
14.6.8.1.5.3. Motion preservation implants
14.6.8.1.5.4. Others
14.6.8.1.6.
Others
14.6.8.2.
Rest of
Asia Pacific Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
14.6.8.2.1.
Bioceramics
14.6.8.2.2.
Polymers
14.6.8.2.3.
Natural
polymers
14.6.8.2.4.
Metals
and alloys
14.6.8.2.5.
Others
14.6.8.3.
Rest of
Asia Pacific Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
14.6.8.3.1.
Allograft
14.6.8.3.2.
Synthetic
14.6.8.3.3.
Xenograft
14.6.8.4.
Rest of
Asia Pacific Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
14.6.8.4.1.
Hospitals
and clinics
14.6.8.4.2.
Specialty
clinics
14.6.8.4.3.
Ambulatory
Centers
14.6.8.4.4.
Dental
clinics
14.6.8.4.5.
Others
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Types
14.7.3. By Materials
14.7.4. By Origin
14.7.5. By End users
15. Middle East and Africa Bio-Implants Market
Analysis and Forecasts, 2022 – 2030
15.1. Overview
15.1.1. Middle East and Africa Bio-Implants Market
Revenue (US$ Mn)
15.2. Middle East and Africa Bio-Implants Market
Revenue (US$ Mn) and Forecasts, By Types
15.2.1. Cardiovascular implants
15.2.1.1.
Stents
15.2.1.2.
Pacing
devices
15.2.1.3.
Grafts
15.2.1.4.
Structural
Cardiac Implants
15.2.1.4.1.
Heart
Valves
15.2.1.4.2.
Tissue
Heart Valves
15.2.1.4.3.
Implantable
Heart Monitors
15.2.1.4.4.
Insertable
Loop Recorders
15.2.1.4.5.
Others
15.2.2. Orthopedic Implants and trauma
15.2.2.1.
Knee
replacement implants
15.2.2.2.
Hip
replacement implants
15.2.2.3.
Ankle
replacement implants
15.2.2.4.
Shoulder
replacement implants
15.2.2.5.
Others
15.2.3. Dental Implants
15.2.3.1.
Endosteal
implants
15.2.3.2.
Subperiosteal
implants
15.2.4. Ophthalmic implants
15.2.4.1.
Intraocular
lens
15.2.4.2.
Glaucoma
and other Lenses
15.2.5. Spinal Implants
15.2.5.1.
Cervical
implants
15.2.5.2.
Thoracolumbar
implants
15.2.5.3.
Motion
preservation implants
15.2.5.4.
Others
15.2.6. Others
15.3. Middle East and Africa Bio-Implants Market
Revenue (US$ Mn) and Forecasts, By Materials
15.3.1. Bioceramics
15.3.2. Polymers
15.3.3. Natural polymers
15.3.4. Metals and alloys
15.3.5. Others
15.4. Middle East and Africa Bio-Implants Market
Revenue (US$ Mn) and Forecasts, By Origin
15.4.1. Allograft
15.4.2. Synthetic
15.4.3. Xenograft
15.5. Middle East and Africa Bio-Implants Market
Revenue (US$ Mn) and Forecasts, By End users
15.5.1. Hospitals and clinics
15.5.2. Specialty clinics
15.5.3. Ambulatory Centers
15.5.4. Dental clinics
15.5.5. Others
15.6. Middle East and Africa Bio-Implants Market
Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1.
Saudi
Arabia Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
15.6.1.1.1.
Cardiovascular
implants
15.6.1.1.1.1. Stents
15.6.1.1.1.2. Pacing devices
15.6.1.1.1.3. Grafts
15.6.1.1.1.4. Structural Cardiac Implants
15.6.1.1.1.4.1. Heart Valves
15.6.1.1.1.4.2. Tissue Heart Valves
15.6.1.1.1.4.3. Implantable Heart Monitors
15.6.1.1.1.4.4. Insertable Loop Recorders
15.6.1.1.1.4.5. Others
15.6.1.1.2.
Orthopedic
Implants and trauma
15.6.1.1.2.1. Knee replacement implants
15.6.1.1.2.2. Hip replacement implants
15.6.1.1.2.3. Ankle replacement implants
15.6.1.1.2.4. Shoulder replacement implants
15.6.1.1.2.5. Others
15.6.1.1.3.
Dental
Implants
15.6.1.1.3.1. Endosteal implants
15.6.1.1.3.2. Subperiosteal implants
15.6.1.1.4.
Ophthalmic
implants
15.6.1.1.4.1. Intraocular lens
15.6.1.1.4.2. Glaucoma and other Lenses
15.6.1.1.5.
Spinal
Implants
15.6.1.1.5.1. Cervical implants
15.6.1.1.5.2. Thoracolumbar implants
15.6.1.1.5.3. Motion preservation implants
15.6.1.1.5.4. Others
15.6.1.1.6.
Others
15.6.1.2.
Saudi
Arabia Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
15.6.1.2.1.
Bioceramics
15.6.1.2.2.
Polymers
15.6.1.2.3.
Natural
polymers
15.6.1.2.4.
Metals
and alloys
15.6.1.2.5.
Others
15.6.1.3.
Saudi
Arabia Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
15.6.1.3.1.
Allograft
15.6.1.3.2.
Synthetic
15.6.1.3.3.
Xenograft
15.6.1.4.
Saudi
Arabia Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
15.6.1.4.1.
Hospitals
and clinics
15.6.1.4.2.
Specialty
clinics
15.6.1.4.3.
Ambulatory
Centers
15.6.1.4.4.
Dental
clinics
15.6.1.4.5.
Others
15.6.2. UAE
15.6.2.1.
UAE Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
15.6.2.1.1.
Cardiovascular
implants
15.6.2.1.1.1. Stents
15.6.2.1.1.2. Pacing devices
15.6.2.1.1.3. Grafts
15.6.2.1.1.4. Structural Cardiac Implants
15.6.2.1.1.4.1. Heart Valves
15.6.2.1.1.4.2. Tissue Heart Valves
15.6.2.1.1.4.3. Implantable Heart Monitors
15.6.2.1.1.4.4. Insertable Loop Recorders
15.6.2.1.1.4.5. Others
15.6.2.1.2.
Orthopedic
Implants and trauma
15.6.2.1.2.1. Knee replacement implants
15.6.2.1.2.2. Hip replacement implants
15.6.2.1.2.3. Ankle replacement implants
15.6.2.1.2.4. Shoulder replacement implants
15.6.2.1.2.5. Others
15.6.2.1.3.
Dental
Implants
15.6.2.1.3.1. Endosteal implants
15.6.2.1.3.2. Subperiosteal implants
15.6.2.1.4.
Ophthalmic
implants
15.6.2.1.4.1. Intraocular lens
15.6.2.1.4.2. Glaucoma and other Lenses
15.6.2.1.5.
Spinal
Implants
15.6.2.1.5.1. Cervical implants
15.6.2.1.5.2. Thoracolumbar implants
15.6.2.1.5.3. Motion preservation implants
15.6.2.1.5.4. Others
15.6.2.1.6.
Others
15.6.2.2.
UAE Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
15.6.2.2.1.
Bioceramics
15.6.2.2.2.
Polymers
15.6.2.2.3.
Natural
polymers
15.6.2.2.4.
Metals
and alloys
15.6.2.2.5.
Others
15.6.2.3.
UAE Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
15.6.2.3.1.
Allograft
15.6.2.3.2.
Synthetic
15.6.2.3.3.
Xenograft
15.6.2.4.
UAE Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
15.6.2.4.1.
Hospitals
and clinics
15.6.2.4.2.
Specialty
clinics
15.6.2.4.3.
Ambulatory
Centers
15.6.2.4.4.
Dental
clinics
15.6.2.4.5.
Others
15.6.3. Egypt
15.6.3.1.
Egypt Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
15.6.3.1.1.
Cardiovascular
implants
15.6.3.1.1.1. Stents
15.6.3.1.1.2. Pacing devices
15.6.3.1.1.3. Grafts
15.6.3.1.1.4. Structural Cardiac Implants
15.6.3.1.1.4.1. Heart Valves
15.6.3.1.1.4.2. Tissue Heart Valves
15.6.3.1.1.4.3. Implantable Heart Monitors
15.6.3.1.1.4.4. Insertable Loop Recorders
15.6.3.1.1.4.5. Others
15.6.3.1.2.
Orthopedic
Implants and trauma
15.6.3.1.2.1. Knee replacement implants
15.6.3.1.2.2. Hip replacement implants
15.6.3.1.2.3. Ankle replacement implants
15.6.3.1.2.4. Shoulder replacement implants
15.6.3.1.2.5. Others
15.6.3.1.3.
Dental
Implants
15.6.3.1.3.1. Endosteal implants
15.6.3.1.3.2. Subperiosteal implants
15.6.3.1.4.
Ophthalmic
implants
15.6.3.1.4.1. Intraocular lens
15.6.3.1.4.2. Glaucoma and other Lenses
15.6.3.1.5.
Spinal
Implants
15.6.3.1.5.1. Cervical implants
15.6.3.1.5.2. Thoracolumbar implants
15.6.3.1.5.3. Motion preservation implants
15.6.3.1.5.4. Others
15.6.3.1.6.
Others
15.6.3.2.
Egypt Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
15.6.3.2.1.
Bioceramics
15.6.3.2.2.
Polymers
15.6.3.2.3.
Natural
polymers
15.6.3.2.4.
Metals
and alloys
15.6.3.2.5.
Others
15.6.3.3.
Egypt Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
15.6.3.3.1.
Allograft
15.6.3.3.2.
Synthetic
15.6.3.3.3.
Xenograft
15.6.3.4.
Egypt Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
15.6.3.4.1.
Hospitals
and clinics
15.6.3.4.2.
Specialty
clinics
15.6.3.4.3.
Ambulatory
Centers
15.6.3.4.4.
Dental
clinics
15.6.3.4.5.
Others
15.6.4. Kuwait
15.6.4.1.
Kuwait Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
15.6.4.1.1.
Cardiovascular
implants
15.6.4.1.1.1. Stents
15.6.4.1.1.2. Pacing devices
15.6.4.1.1.3. Grafts
15.6.4.1.1.4. Structural Cardiac Implants
15.6.4.1.1.4.1. Heart Valves
15.6.4.1.1.4.2. Tissue Heart Valves
15.6.4.1.1.4.3. Implantable Heart Monitors
15.6.4.1.1.4.4. Insertable Loop Recorders
15.6.4.1.1.4.5. Others
15.6.4.1.2.
Orthopedic
Implants and trauma
15.6.4.1.2.1. Knee replacement implants
15.6.4.1.2.2. Hip replacement implants
15.6.4.1.2.3. Ankle replacement implants
15.6.4.1.2.4. Shoulder replacement implants
15.6.4.1.2.5. Others
15.6.4.1.3.
Dental
Implants
15.6.4.1.3.1. Endosteal implants
15.6.4.1.3.2. Subperiosteal implants
15.6.4.1.4.
Ophthalmic
implants
15.6.4.1.4.1. Intraocular lens
15.6.4.1.4.2. Glaucoma and other Lenses
15.6.4.1.5.
Spinal
Implants
15.6.4.1.5.1. Cervical implants
15.6.4.1.5.2. Thoracolumbar implants
15.6.4.1.5.3. Motion preservation implants
15.6.4.1.5.4. Others
15.6.4.1.6.
Others
15.6.4.2.
Kuwait Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
15.6.4.2.1.
Bioceramics
15.6.4.2.2.
Polymers
15.6.4.2.3.
Natural
polymers
15.6.4.2.4.
Metals
and alloys
15.6.4.2.5.
Others
15.6.4.3.
Kuwait Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
15.6.4.3.1.
Allograft
15.6.4.3.2.
Synthetic
15.6.4.3.3.
Xenograft
15.6.4.4.
Kuwait Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
15.6.4.4.1.
Hospitals
and clinics
15.6.4.4.2.
Specialty
clinics
15.6.4.4.3.
Ambulatory
Centers
15.6.4.4.4.
Dental
clinics
15.6.4.4.5.
Others
15.6.5. South Africa
15.6.5.1.
South
Africa Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
15.6.5.1.1.
Cardiovascular
implants
15.6.5.1.1.1. Stents
15.6.5.1.1.2. Pacing devices
15.6.5.1.1.3. Grafts
15.6.5.1.1.4. Structural Cardiac Implants
15.6.5.1.1.4.1. Heart Valves
15.6.5.1.1.4.2. Tissue Heart Valves
15.6.5.1.1.4.3. Implantable Heart Monitors
15.6.5.1.1.4.4. Insertable Loop Recorders
15.6.5.1.1.4.5. Others
15.6.5.1.2.
Orthopedic
Implants and trauma
15.6.5.1.2.1. Knee replacement implants
15.6.5.1.2.2. Hip replacement implants
15.6.5.1.2.3. Ankle replacement implants
15.6.5.1.2.4. Shoulder replacement implants
15.6.5.1.2.5. Others
15.6.5.1.3.
Dental
Implants
15.6.5.1.3.1. Endosteal implants
15.6.5.1.3.2. Subperiosteal implants
15.6.5.1.4.
Ophthalmic
implants
15.6.5.1.4.1. Intraocular lens
15.6.5.1.4.2. Glaucoma and other Lenses
15.6.5.1.5.
Spinal
Implants
15.6.5.1.5.1. Cervical implants
15.6.5.1.5.2. Thoracolumbar implants
15.6.5.1.5.3. Motion preservation implants
15.6.5.1.5.4. Others
15.6.5.1.6.
Others
15.6.5.2.
South
Africa Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
15.6.5.2.1.
Bioceramics
15.6.5.2.2.
Polymers
15.6.5.2.3.
Natural
polymers
15.6.5.2.4.
Metals
and alloys
15.6.5.2.5.
Others
15.6.5.3.
South
Africa Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
15.6.5.3.1.
Allograft
15.6.5.3.2.
Synthetic
15.6.5.3.3.
Xenograft
15.6.5.4.
South
Africa Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
15.6.5.4.1.
Hospitals
and clinics
15.6.5.4.2.
Specialty
clinics
15.6.5.4.3.
Ambulatory
Centers
15.6.5.4.4.
Dental
clinics
15.6.5.4.5.
Others
15.6.6. Rest of Middle East & Africa
15.6.6.1.
Rest of
Middle East & Africa Bio-Implants Market Revenue (US$ Mn) and Forecasts, By
Types
15.6.6.1.1.
Cardiovascular
implants
15.6.6.1.1.1. Stents
15.6.6.1.1.2. Pacing devices
15.6.6.1.1.3. Grafts
15.6.6.1.1.4. Structural Cardiac Implants
15.6.6.1.1.4.1. Heart Valves
15.6.6.1.1.4.2. Tissue Heart Valves
15.6.6.1.1.4.3. Implantable Heart Monitors
15.6.6.1.1.4.4. Insertable Loop Recorders
15.6.6.1.1.4.5. Others
15.6.6.1.2.
Orthopedic
Implants and trauma
15.6.6.1.2.1. Knee replacement implants
15.6.6.1.2.2. Hip replacement implants
15.6.6.1.2.3. Ankle replacement implants
15.6.6.1.2.4. Shoulder replacement implants
15.6.6.1.2.5. Others
15.6.6.1.3.
Dental
Implants
15.6.6.1.3.1. Endosteal implants
15.6.6.1.3.2. Subperiosteal implants
15.6.6.1.4.
Ophthalmic
implants
15.6.6.1.4.1. Intraocular lens
15.6.6.1.4.2. Glaucoma and other Lenses
15.6.6.1.5.
Spinal
Implants
15.6.6.1.5.1. Cervical implants
15.6.6.1.5.2. Thoracolumbar implants
15.6.6.1.5.3. Motion preservation implants
15.6.6.1.5.4. Others
15.6.6.1.6.
Others
15.6.6.2.
Rest of
Middle East & Africa Bio-Implants Market Revenue (US$ Mn) and Forecasts, By
Materials
15.6.6.2.1.
Bioceramics
15.6.6.2.2.
Polymers
15.6.6.2.3.
Natural
polymers
15.6.6.2.4.
Metals
and alloys
15.6.6.2.5.
Others
15.6.6.3.
Rest of
Middle East & Africa Bio-Implants Market Revenue (US$ Mn) and Forecasts, By
Origin
15.6.6.3.1.
Allograft
15.6.6.3.2.
Synthetic
15.6.6.3.3.
Xenograft
15.6.6.4.
Rest of
Middle East & Africa Bio-Implants Market Revenue (US$ Mn) and Forecasts, By
End users
15.6.6.4.1.
Hospitals
and clinics
15.6.6.4.2.
Specialty
clinics
15.6.6.4.3.
Ambulatory
Centers
15.6.6.4.4.
Dental
clinics
15.6.6.4.5.
Others
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Types
15.7.3. By Materials
15.7.4. By Origin
15.7.5. By End users
16. Latin America Bio-Implants Market Analysis
and Forecasts, 2022 – 2030
16.1. Overview
16.1.1. Latin America Bio-Implants Market Revenue
(US$ Mn)
16.2. Latin America Bio-Implants Market Revenue
(US$ Mn) and Forecasts, By Types
16.2.1. Cardiovascular implants
16.2.1.1.
Stents
16.2.1.2.
Pacing
devices
16.2.1.3.
Grafts
16.2.1.4.
Structural
Cardiac Implants
16.2.1.4.1.
Heart
Valves
16.2.1.4.2.
Tissue
Heart Valves
16.2.1.4.3.
Implantable
Heart Monitors
16.2.1.4.4.
Insertable
Loop Recorders
16.2.1.4.5.
Others
16.2.2. Orthopedic Implants and trauma
16.2.2.1.
Knee
replacement implants
16.2.2.2.
Hip
replacement implants
16.2.2.3.
Ankle
replacement implants
16.2.2.4.
Shoulder
replacement implants
16.2.2.5.
Others
16.2.3. Dental Implants
16.2.3.1.
Endosteal
implants
16.2.3.2.
Subperiosteal
implants
16.2.4. Ophthalmic implants
16.2.4.1.
Intraocular
lens
16.2.4.2.
Glaucoma
and other Lenses
16.2.5. Spinal Implants
16.2.5.1.
Cervical
implants
16.2.5.2.
Thoracolumbar
implants
16.2.5.3.
Motion
preservation implants
16.2.5.4.
Others
16.2.6. Others
16.3. Latin America Bio-Implants Market Revenue
(US$ Mn) and Forecasts, By Materials
16.3.1. Bioceramics
16.3.2. Polymers
16.3.3. Natural polymers
16.3.4. Metals and alloys
16.3.5. Others
16.4. Latin America Bio-Implants Market Revenue
(US$ Mn) and Forecasts, By Origin
16.4.1. Allograft
16.4.2. Synthetic
16.4.3. Xenograft
16.5. Latin America Bio-Implants Market Revenue
(US$ Mn) and Forecasts, By End users
16.5.1. Hospitals and clinics
16.5.2. Specialty clinics
16.5.3. Ambulatory Centers
16.5.4. Dental clinics
16.5.5. Others
16.6. Latin America Bio-Implants Market Revenue
(US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1.
Brazil Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Types
16.6.1.1.1.
Cardiovascular
implants
16.6.1.1.1.1. Stents
16.6.1.1.1.2. Pacing devices
16.6.1.1.1.3. Grafts
16.6.1.1.1.4. Structural Cardiac Implants
16.6.1.1.1.4.1. Heart Valves
16.6.1.1.1.4.2. Tissue Heart Valves
16.6.1.1.1.4.3. Implantable Heart Monitors
16.6.1.1.1.4.4. Insertable Loop Recorders
16.6.1.1.1.4.5. Others
16.6.1.1.2.
Orthopedic
Implants and trauma
16.6.1.1.2.1. Knee replacement implants
16.6.1.1.2.2. Hip replacement implants
16.6.1.1.2.3. Ankle replacement implants
16.6.1.1.2.4. Shoulder replacement implants
16.6.1.1.2.5. Others
16.6.1.1.3.
Dental
Implants
16.6.1.1.3.1. Endosteal implants
16.6.1.1.3.2. Subperiosteal implants
16.6.1.1.4.
Ophthalmic
implants
16.6.1.1.4.1. Intraocular lens
16.6.1.1.4.2. Glaucoma and other Lenses
16.6.1.1.5.
Spinal
Implants
16.6.1.1.5.1. Cervical implants
16.6.1.1.5.2. Thoracolumbar implants
16.6.1.1.5.3. Motion preservation implants
16.6.1.1.5.4. Others
16.6.1.1.6.
Others
16.6.1.2.
Brazil Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Materials
16.6.1.2.1.
Bioceramics
16.6.1.2.2.
Polymers
16.6.1.2.3.
Natural
polymers
16.6.1.2.4.
Metals
and alloys
16.6.1.2.5.
Others
16.6.1.3.
Brazil Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By Origin
16.6.1.3.1.
Allograft
16.6.1.3.2.
Synthetic
16.6.1.3.3.
Xenograft
16.6.1.4.
Brazil Bio-Implants
Market Revenue (US$ Mn) and Forecasts, By End users
16.6.1.4.1.
Hospitals
and clinics
16.6.1.4.2.
Specialty
clinics
16.6.1.4.3.
Ambulatory
Centers
16.6.1.4.4.
Dental
clinics
16.6.1.4.5.
Others
16.6.2. Argentina
16.6.2.1.
Argentina
Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
16.6.2.1.1.
Cardiovascular
implants
16.6.2.1.1.1. Stents
16.6.2.1.1.2. Pacing devices
16.6.2.1.1.3. Grafts
16.6.2.1.1.4. Structural Cardiac Implants
16.6.2.1.1.4.1. Heart Valves
16.6.2.1.1.4.2. Tissue Heart Valves
16.6.2.1.1.4.3. Implantable Heart Monitors
16.6.2.1.1.4.4. Insertable Loop Recorders
16.6.2.1.1.4.5. Others
16.6.2.1.2.
Orthopedic
Implants and trauma
16.6.2.1.2.1. Knee replacement implants
16.6.2.1.2.2. Hip replacement implants
16.6.2.1.2.3. Ankle replacement implants
16.6.2.1.2.4. Shoulder replacement implants
16.6.2.1.2.5. Others
16.6.2.1.3.
Dental
Implants
16.6.2.1.3.1. Endosteal implants
16.6.2.1.3.2. Subperiosteal implants
16.6.2.1.4.
Ophthalmic
implants
16.6.2.1.4.1. Intraocular lens
16.6.2.1.4.2. Glaucoma and other Lenses
16.6.2.1.5.
Spinal
Implants
16.6.2.1.5.1. Cervical implants
16.6.2.1.5.2. Thoracolumbar implants
16.6.2.1.5.3. Motion preservation implants
16.6.2.1.5.4. Others
16.6.2.1.6.
Others
16.6.2.2.
Argentina
Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
16.6.2.2.1.
Bioceramics
16.6.2.2.2.
Polymers
16.6.2.2.3.
Natural
polymers
16.6.2.2.4.
Metals
and alloys
16.6.2.2.5.
Others
16.6.2.3.
Argentina
Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
16.6.2.3.1.
Allograft
16.6.2.3.2.
Synthetic
16.6.2.3.3.
Xenograft
16.6.2.4.
Argentina
Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
16.6.2.4.1.
Hospitals
and clinics
16.6.2.4.2.
Specialty
clinics
16.6.2.4.3.
Ambulatory
Centers
16.6.2.4.4.
Dental
clinics
16.6.2.4.5.
Others
16.6.3. Rest of Latin America
16.6.3.1.
Rest of
Latin America Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Types
16.6.3.1.1.
Cardiovascular
implants
16.6.3.1.1.1. Stents
16.6.3.1.1.2. Pacing devices
16.6.3.1.1.3. Grafts
16.6.3.1.1.4. Structural Cardiac Implants
16.6.3.1.1.4.1. Heart Valves
16.6.3.1.1.4.2. Tissue Heart Valves
16.6.3.1.1.4.3. Implantable Heart Monitors
16.6.3.1.1.4.4. Insertable Loop Recorders
16.6.3.1.1.4.5. Others
16.6.3.1.2.
Orthopedic
Implants and trauma
16.6.3.1.2.1. Knee replacement implants
16.6.3.1.2.2. Hip replacement implants
16.6.3.1.2.3. Ankle replacement implants
16.6.3.1.2.4. Shoulder replacement implants
16.6.3.1.2.5. Others
16.6.3.1.3.
Dental
Implants
16.6.3.1.3.1. Endosteal implants
16.6.3.1.3.2. Subperiosteal implants
16.6.3.1.4.
Ophthalmic
implants
16.6.3.1.4.1. Intraocular lens
16.6.3.1.4.2. Glaucoma and other Lenses
16.6.3.1.5.
Spinal
Implants
16.6.3.1.5.1. Cervical implants
16.6.3.1.5.2. Thoracolumbar implants
16.6.3.1.5.3. Motion preservation implants
16.6.3.1.5.4. Others
16.6.3.1.6.
Others
16.6.3.2.
Rest of
Latin America Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Materials
16.6.3.2.1.
Bioceramics
16.6.3.2.2.
Polymers
16.6.3.2.3.
Natural
polymers
16.6.3.2.4.
Metals
and alloys
16.6.3.2.5.
Others
16.6.3.3.
Rest of
Latin America Bio-Implants Market Revenue (US$ Mn) and Forecasts, By Origin
16.6.3.3.1.
Allograft
16.6.3.3.2.
Synthetic
16.6.3.3.3.
Xenograft
16.6.3.4.
Rest of
Latin America Bio-Implants Market Revenue (US$ Mn) and Forecasts, By End users
16.6.3.4.1.
Hospitals
and clinics
16.6.3.4.2.
Specialty
clinics
16.6.3.4.3.
Ambulatory
Centers
16.6.3.4.4.
Dental
clinics
16.6.3.4.5.
Others
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Types
16.7.3. By Materials
16.7.4. By Origin
16.7.5. By End users
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market Share Analysis, 2021
17.3. Global Presence and Growth Strategies
17.3.1. Mergers and Acquisitions
17.3.2. Product Launches
17.3.3. Investments Trends
17.3.4. R&D Initiatives
18. Player Profiles
18.1. Alpha-Bio Tec Ltd.
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Arthrex, Inc.
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Auxein Medical
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. BioHorizons
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. BioImplant Ceramic
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. Biorad Medisys Pvt Ltd.
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. Biotec
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. Exactech, Inc.
18.8.1. Company Details
18.8.2. Company Overview
18.8.3. Product Offerings
18.8.4. Key Developments
18.8.5. Financial Analysis
18.8.6. SWOT Analysis
18.8.7. Business Strategies
18.9. Medical Devices Business Services, Inc.
18.9.1. Company Details
18.9.2. Company Overview
18.9.3. Product Offerings
18.9.4. Key Developments
18.9.5. Financial Analysis
18.9.6. SWOT Analysis
18.9.7. Business Strategies
18.10. Medtronic
18.10.1. Company Details
18.10.2. Company Overview
18.10.3. Product Offerings
18.10.4. Key Developments
18.10.5. Financial Analysis
18.10.6. SWOT Analysis
18.10.7. Business Strategies
18.11. Redline Surgical.
18.11.1. Company Details
18.11.2. Company Overview
18.11.3. Product Offerings
18.11.4. Key Developments
18.11.5. Financial Analysis
18.11.6. SWOT Analysis
18.11.7. Business Strategies
18.12. Straumann USA, LLC
18.12.1. Company Details
18.12.2. Company Overview
18.12.3. Product Offerings
18.12.4. Key Developments
18.12.5. Financial Analysis
18.12.6. SWOT Analysis
18.12.7. Business Strategies
18.13. Stryker
18.13.1. Company Details
18.13.2. Company Overview
18.13.3. Product Offerings
18.13.4. Key Developments
18.13.5. Financial Analysis
18.13.6. SWOT Analysis
18.13.7. Business Strategies
18.14. UX Themes
18.14.1. Company Details
18.14.2. Company Overview
18.14.3. Product Offerings
18.14.4. Key Developments
18.14.5. Financial Analysis
18.14.6. SWOT Analysis
18.14.7. Business Strategies
18.15. Zimmer Biomet
18.15.1. Company Details
18.15.2. Company Overview
18.15.3. Product Offerings
18.15.4. Key Developments
18.15.5. Financial Analysis
18.15.6. SWOT Analysis
18.15.7. Business Strategies
18.16. Other Market Participants
19. Key Findings
Note: This ToC is tentative and
can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.